Literature DB >> 10461484

Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patients.

B Seriolo1, S Accardo, A Garnero, D Fasciolo, M Cutolo.   

Abstract

OBJECTIVE: To investigate plasma levels of natural anticoagulant proteins such as protein S, protein C and antithrombin III in a selected population of patients with rheumatoid arthritis (RA) with and without anticardiolipin antibody (aCL) positivity, and to evaluate the possible relationships with an increased risk of thrombotic events in RA.
METHODS: A total of 184 female RA patients attending our Extra-Articular Involvement RA Clinic were evaluated for aCL levels, total and free protein S, protein C and antithrombin III concentrations, and for the occurrence of thrombotic events. Patients were grouped as aCL positive (n = 35) and aCL negative (n = 149).
RESULTS: Higher rates of venous and/or arterial thromboses were diagnosed in patients with RA compared to controls (P = 0.01). In particular, lower free protein S levels were found in aCL-positive patients with RA compared to both aCL-negative patients and controls (P = 0.001). Functional assays for protein C, antithrombin III as well as total protein S levels were found to be in the normal range in all patients and controls.
CONCLUSION: The association observed between aCL positivity and decreased levels of free protein S in RA patients may represent one of the risk factors for thrombotic events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461484     DOI: 10.1093/rheumatology/38.7.675

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  Coagulopathies and inflammatory diseases: '…glimpse of a Snark'.

Authors:  Silvina Del Carmen; Sophie M Hapak; Sourav Ghosh; Carla V Rothlin
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

Review 2.  The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis.

Authors:  Ewa Olech; Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

3.  Complications of primary total hip arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and primary osteoarthritis.

Authors:  Qiang Lian; Yun Lian; Kangxian Li; Qinfeng Yang; Kunlian Li; Yiqiao Zheng; Haibing Liu; Zhanjun Shi; Jian Wang
Journal:  BMC Musculoskelet Disord       Date:  2022-10-19       Impact factor: 2.562

4.  The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.

Authors:  Marie Hudson; Andrée-Laure Herr; Joyce Rauch; Carolyn Neville; Erika Chang; Reda Ibrahim; Chantal Séguin; Jeannine Kassis; Lambert Busque; Paul R Fortin
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

5.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Authors:  W Miehsler; W Reinisch; E Valic; W Osterode; W Tillinger; T Feichtenschlager; J Grisar; K Machold; S Scholz; H Vogelsang; G Novacek
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

6.  Antiphospholipid antibodies during 6-month treatment with infliximab: a preliminary report.

Authors:  Bogdan Kolarz; Maria Majdan; Dorota A Darmochwal-Kolarz; Magdalena Dryglewska
Journal:  Med Sci Monit       Date:  2014-07-16

7.  The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians.

Authors:  Juan-Sebastian Franco; Nicolás Molano-González; Monica Rodríguez-Jiménez; Yeny Acosta-Ampudia; Rubén D Mantilla; Jenny Amaya-Amaya; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

Review 8.  Advances in the Research on Anticardiolipin Antibody.

Authors:  Dan Wang; Wenxin Lv; Shichang Zhang; Jiexin Zhang
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

Review 9.  Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies.

Authors:  Mir Sohail Fazeli; Vadim Khaychuk; Keith Wittstock; Boris Breznen; Grace Crocket; Mir-Masoud Pourrahmat; Leticia Ferri
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.